AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2022
Dec 12, 2022
34395_dirs_2022-12-12_90a90a70-ec80-4aa6-ab5e-daf38718923f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-12-08-05:00
Reporting Person: Plummer Nicholas (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-08-05:00 | Common Stock | P | 4800 | $2.07 | Acquired | 51494 | Direct |
More from VOLITIONRX LTD
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 5
Proxy Solicitation & Information Statement
2026
Jun 2
Capital/Financing Update
2026
May 22
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 14
Report Publication Announcement
2026
May 14
Proxy Solicitation & Information Statement
2026
May 13
Annual Report
2026
Apr 30